Skip to content

Dr. ROMBOUTS-MICHIELS

Active
Private limited companyfounded 2007active for 19 yearsSt. Antoniusbaan 161, 2980 Zoersel, BelgiumKBO/BCE: BE 0889.399.631
Summary

Dr. ROMBOUTS-MICHIELS has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €501,692 and a net result of -€16,728. Equity has been stable since 2018 (±0.7% per year). Its solvency ranks better than 74% of 3,024 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 11-05-2007 Normal situation
Activity
General medical practice NACE 86210and 2 others
Establishment unit
2.163.679.624 2980 Zoersel, since 09-05-2007
Financial year end
31 December
Peppol
Reachable since 18-12-2025

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€8,564
▼ 3.3%
Turnover
≈ €58,000
estimated
Loss
€16,728
▲ 25.5%
Equity
€501,692
▼ 3.2%
Total assets
€609,214
▼ 5.4%
Filed on 19-06-2026, 42 days before the deadline
Score breakdownraises riskLoss of €16,728, the second in a row (financial year 2025)lowers riskSector: Human health activities (NACE 86)Size: total assets €609,214Liquidity: current ratio 6.79, cash €95,740Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 42% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 82.4% of total assets
Liquidity 69+4
short-term debt 11.1% · cash 15.7%
Profitability 26-4
return on assets -2.7%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: 0.1%▲ +0.1 percentage points vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.2%▲ +0.1 percentage points vs 08-2025highest value 10-2025: 0.1%▼ -0.1 percentage points vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: < 0.1%▼ -0.1 percentage points vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €45,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 6.79 (6.8 in 2024), above the usual 1.5. Short-term debt is 11.1% and cash 15.7% of total assets. 17.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 49% on liquidity, 5% on profitability and 31% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €609,214
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Loss of €16,728, the second in a row (financial year 2025)
NBB · annual accounts
lowers risk · Liquidity: current ratio 6.79, cash €95,740
NBB · annual accounts
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
1819202122232425
2018 to 2025 · latest year -€16,728
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-06-2026, 42 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
42 days early
2024
28 days late
2023
27 days early
2022
31 days late
2021
11 days early
2020
31 days late
2019
70 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 11 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 20 July (4 of the last 5 accounts filed within 39 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Lower net result than 93% of companies in human healthsector median €110,769 · 2,990 companies -€16,728 View
  • Caution: 2 loss-making years in a rowloss in financial year 2025 -€16,728 View

Recent changes

  1. · Gazette deed Registered office moved from Deurne to Zoersel
  2. · Gazette deed Company renamed from BVBA Dr. Rombouts-Michiels to Dr. Rombouts-MichielsReappointments: Rombouts Marc (niet statutairbestuurder) and Michiels Barbara (niet statutairbestuurder)
  3. · Gazette deed Incorporation
All 16 events

Comparable companies

These companies have the same main activity as Dr. ROMBOUTS-MICHIELS: general medical practice (NACE 86210). They are comparable in size and age: total assets between €342,000 and €719,000, founded between 1989 and 2016.

CompanyTotal assetsGross margin
Dr. ROMBOUTS-MICHIELS Zoersel€609,214€8,564
Dokter Kennes Antwerpen€509,096€8,500
DOKTER PHILIPPE COLANS Rumst€718,874€7,660
VIBB Geel€621,457€9,645
DOKTER JOOST KLIJN Brasschaat€365,629€10,437
DOKTERS DAESE & DE WITTE Middelkerke€341,558€7,275
DR. ERIK PEETERS Antwerpen€470,286€11,048
Full comparison

Key facts about Dr. ROMBOUTS-MICHIELS

What is the company number of Dr. ROMBOUTS-MICHIELS?
The company number of Dr. ROMBOUTS-MICHIELS is 0889.399.631. The VAT number is the same number with BE in front: BE 0889.399.631.
Where is Dr. ROMBOUTS-MICHIELS based?
The registered office is at St. Antoniusbaan 161, 2980 Zoersel.Company details
What does Dr. ROMBOUTS-MICHIELS do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. ROMBOUTS-MICHIELS?
The legal form of Dr. ROMBOUTS-MICHIELS is Private limited company (BV).
When was Dr. ROMBOUTS-MICHIELS founded?
Dr. ROMBOUTS-MICHIELS was founded on 11-05-2007.
Is Dr. ROMBOUTS-MICHIELS still active?
Yes, Dr. ROMBOUTS-MICHIELS is an active enterprise in the KBO register.
How many employees does Dr. ROMBOUTS-MICHIELS have?
Dr. ROMBOUTS-MICHIELS had an average of 0.3 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
What is the turnover of Dr. ROMBOUTS-MICHIELS?
The turnover in financial year 2025 is ≈ €58,000. This figure is estimated from the gross margin of €8,564 and 68 comparable companies (NACE 86). It probably lies between €36,000 and €110,000. It is a rough estimate.
Is Dr. ROMBOUTS-MICHIELS profitable?
In financial year 2025, Dr. ROMBOUTS-MICHIELS made a loss of €16,728.
Where can I find the annual accounts of Dr. ROMBOUTS-MICHIELS?
Dr. ROMBOUTS-MICHIELS filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. ROMBOUTS-MICHIELS due?
Dr. ROMBOUTS-MICHIELS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.